Dorsey Wright & Associates’s VEON VEON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.33M Sell
25,399
-10,058
-28% -$524K 0.22% 91
2026
Q1
$1.64M Buy
35,457
+11,129
+46% +$585K 0.2% 98
2025
Q4
$1.28M Buy
24,328
+934
+4% +$47.3K 0.28% 94
2025
Q3
$1.27M Buy
+23,394
New +$1.25M 0.28% 97

Other funds holding VEON

Dorsey Wright & Associates's VEON Position: Q2 2026 in Review

Dorsey Wright & Associates reduced its VEON (VEON) stake by 28% in Q2 2026, selling an estimated $524K and leaving 25,399 shares worth $1.33M. The position accounts for 0.22% of the portfolio, ranked #91.

Dorsey Wright & Associates first reported a position in VEON in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.64M in Q1 2026. 112 funds tracked by Wall St. Rank hold VEON as of Q2 2026.

  • Dorsey Wright & Associates held 25,399 shares of VEON worth $1.33M as of Q2 2026.
  • Dorsey Wright & Associates sold 10,058 VEON shares in Q2 2026, an estimated $524K.
  • VEON made up 0.22% of Dorsey Wright & Associates's portfolio in Q2 2026, its #91 holding.
  • Dorsey Wright & Associates first reported a position in VEON in Q3 2025 and has held it in 4 quarters since.
  • Dorsey Wright & Associates's VEON position peaked at $1.64M in Q1 2026.
  • 112 funds tracked by Wall St. Rank held VEON as of Q2 2026.

Based on Dorsey Wright & Associates's 13F filing for Q2 2026, filed 6 Aug 2026.